Literature DB >> 2903360

Two-year follow-up of biphosphonate (APD) treatment in steroid osteoporosis.

I R Reid, S W Heap, A R King, H K Ibbertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2903360     DOI： 10.1016/s0140-6736(88)90566-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Management of corticosteroid-induced osteoporosis: a clinician's perspective.

Authors:  S L Silverman
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

Review 2.  Prevention and treatment of glucocorticoid-induced osteoporosis.

Authors:  F Eggelmeijer
Journal:  Pharm World Sci       Date:  1998-10

Review 3.  Steroid osteoporosis.

Authors:  I R Reid
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 4.  The therapeutic use of bisphosphonates.

Authors:  J E Compston
Journal:  BMJ       Date:  1994-09-17

Review 5.  Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis.

Authors:  Juliet E Compston
Journal:  Curr Rheumatol Rep       Date:  2007-04       Impact factor: 4.592

Review 6.  Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies.

Authors:  Ian R Reid
Journal:  Skeletal Radiol       Date:  2011-08-17       Impact factor: 2.199

7.  A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.

Authors:  J H Healey; S A Paget; P Williams-Russo; T P Szatrowski; R Schneider; H Spiera; H Mitnick; K Ales; P Schwartzberg
Journal:  Calcif Tissue Int       Date:  1996-02       Impact factor: 4.333

8.  Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study.

Authors:  P Geusens; J Dequeker; J Vanhoof; R Stalmans; S Boonen; J Joly; J Nijs; J Raus
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

9.  Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.

Authors:  I A Campbell; J G Douglas; R M Francis; R J Prescott; D M Reid
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

10.  Infusion rate and pharmacokinetics of intravenous pamidronate in the treatment of tumour-induced hypercalcaemia.

Authors:  D J Dodwell; A Howell; A R Morton; P T Daley-Yates; C R Hoggarth
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.